Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jun 15;10(8):1003-14.
doi: 10.7150/ijms.6437. Print 2013.

Potential function of granulysin, other related effector molecules and lymphocyte subsets in patients with TB and HIV/TB coinfection

Affiliations

Potential function of granulysin, other related effector molecules and lymphocyte subsets in patients with TB and HIV/TB coinfection

Nada Pitabut et al. Int J Med Sci. .

Abstract

Background: Host effector mechanism against Mycobacterium tuberculosis (Mtb) infection is dependent on innate immune response by macrophages and neutrophils and the alterations in balanced adaptive immunity. Coordinated release of cytolytic effector molecules from NK cells and effector T cells and the subsequent granule-associated killing of infected cells have been documented; however, their role in clinical tuberculosis (TB) is still controversy.

Objective: To investigate whether circulating granulysin and other effector molecules are associated with the number of NK cells, iNKT cells, Vγ9(+)Vδ2(+) T cells, CD4(+) T cells and CD8(+) T cells, and such association influences the clinical outcome of the disease in patients with pulmonary TB and HIV/TB coinfection.

Methods: Circulating granulysin, perforin, granzyme-B and IFN-γ levels were determined by ELISA. The isoforms of granulysin were analyzed by Western blot analysis. The effector cells were analyzed by flow cytometry.

Results: Circulating granulysin and perforin levels in TB patients were lower than healthy controls, whereas the granulysin levels in HIV/TB coinfection were much higher than in any other groups, TB and HIV with or without receiving HAART, which corresponded to the number of CD8(+) T cells which kept high, but not with NK cells and other possible cellular sources of granulysin. In addition, the 17kDa, 15kDa and 9kDa isoforms of granulysin were recognized in plasma of HIV/TB coinfection. Increased granulysin and decreased IFN-γ levels in HIV/TB coinfection and TB after completion of anti-TB therapy were observed.

Conclusion: The results suggested that the alteration of circulating granulysin has potential function in host immune response against TB and HIV/TB coinfection. This is the first demonstration so far of granulysin in HIV/TB coinfection.

Keywords: Granulysin; HIV; HIV/TB Coinfection; Lymphocytes Subsets.; TB.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interest exists.

Figures

Fig 1
Fig 1
Circulating granulysin (ng/ml) (A), perforin (pg/ml) (B), granzyme-B (pg/ml) (C) and IFN-γ (pg/ml) (D) levels before anti-TB therapy in Thai patients with HIV/TB coinfection and TB in comparison with healthy controls (HC), HIV+HAART- and HIV+HAART+. Each dot represented one individual. A horizontal bar indicated the median of each group. *, p <0.05; **, p <0.01.
Fig 2
Fig 2
Isoforms of granulysin expression in plasma from Thai patients by Western blot analysis. Lane 1-3, HIV/TB coinfection plasma, 3 bands of ∼17kDa, 15kDa and 9kDa isoforms; Lanes: 4-6, TB plasma, I band of ∼17kDa isoform (Lane 4) and 2 bands of ∼15kDa and 9kDa isoforms (Lane 5-6); Lane 7, 2 bands of HC ∼15kDa and 9kDa isoforms.
Fig 3
Fig 3
The number of NK cells (A), iNKT cells (B), Vγ9+Vδ2+ T cells (C), CD4+ T cells (D) and CD8+ T cells (E) per microliter (µl) in Thai patients with HIV/TB coinfection and TB in comparison with healthy controls (HC), HIV+HAART- and HIV+HAART+ determined by flow cytometric analysis. Each dot represented one individual. A horizontal bar indicated the median of each group. *, p <0.05; **, p <0.01.
Fig 4
Fig 4
Circulating granulysin (ng/ml) and IFN-γ (pg/ml) in Thai patients with HIV/TB coinfection (A and C) and patients with TB (B and D) before and after completion of anti-TB therapy. Each dot represented one individual. *, p <0.05.
Fig 5
Fig 5
Circulating granulysin (ng/ml) in Japanese patients with HIV/TB coinfection before anti-TB therapy, HIV+HAART- and healthy controls (HC). Each dot represented one individual. A horizontal bar indicated the median of each group. *, p <0.05.

Similar articles

Cited by

References

    1. Global Tuberculosis report 2012. Geneva, Switzerland: WHO; http://www.who.int/tb/publications/global_report/en/
    1. Whalen C, Horsburgh CR, Hom D, Lahart C, Simberkoff M, Ellner J. Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Respir Crit Care Med. 1995;151:129–35. - PubMed
    1. Goletti D, Weissman D, Jackson RW. et al. Effect of Mycobacterium tuberculosis on HIV replication: role of immune activation. J Immunol. 1996;157:1271–8. - PubMed
    1. Hazenberg MD, Hamann D, Schuitemaker H, Miedema F. T cell depletion in HIV-1 infection: How CD4+ T cells go out of stock. Nat Immunol. 2000;1:285–289. - PubMed
    1. Dietrich CR, Flynn JL. HIV-1/Mycobacterium tuberculosis Coinfection Immunology: How Does HIV-1 Exacerbate Tuberculosis? Infect Immun. 2011;79:1407–17. - PMC - PubMed

Publication types

Substances